Trials / Enrolling By Invitation
Enrolling By InvitationNCT04066608
Prevalence of Advanced Fibrosis in Patients Living With HIV
Cross-sectional Study on the Prevalence of Fatty Liver and Metabolic Risk Factors in an HIV-infected Population
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Johannes Gutenberg University Mainz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Monocentric, cross-sectional study to define the prevalence of advanced fibrosis in an HIV infected outpatient population. Follow-up over 10 years to assess clinical relevance.
Detailed description
Globally a shift in the spectrum of diseases has occurred. While in earlier year's infectious (communicable) disease were the main contributors to morbidity and mortality, today non-communicable diseases (NCD) exhibit a dramatic increase and have reached epidemic proportions, even in developing countries. Diabetes, cardiovascular disease, and cancer are the most frequent NCDs and the underlying risk factors including Insulin resistance, dyslipidemia and obesity have been increasing over the last decades. The current study explores the prevalence of advanced fibrosis in an HIV-infected outpatient study population.
Conditions
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2028-10-01
- Completion
- 2028-10-01
- First posted
- 2019-08-26
- Last updated
- 2023-12-28
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04066608. Inclusion in this directory is not an endorsement.